Trial Profile
Retrospective study investigating efficacy of treatment of pan-drug resistant Acinetobacter baumannii (PDRAB) infection with combination regimen of meropenem, cefoperazone-sulbactam and minocycline in extensive burns patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Cefoperazone/sulbactam (Primary) ; Meropenem (Primary) ; Minocycline (Primary)
- Indications Acinetobacter infections
- Focus Therapeutic Use
- 04 Dec 2015 New trial record